Latest News and Press Releases

Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech company developing RNA interference...

Grand Cayman, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi)...

NGS target enrichment solutions innovator Paragon Genomics and pioneering oncology diagnostics firm Genecast have formed a global strategic partnership.

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Japan Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9), By Delivery Method (Ex Vivo), By Application (Genetic...

Houston, July 24, 2025 (GLOBE NEWSWIRE) -- Biostate AI uses RNA sequencing, a snapshot of gene activity, to build AI models that accurately guide drug development, therapy selection, and...

Grand Cayman, Cayman Islands, July 16, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA...

Grand Cayman, Cayman Islands, July 09, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA...

Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "Innovations in Extracellular Vesicles Research 2025: Technologies, Tools, Demos & Applications" conference has been added to ...

Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "Gene and Cell Therapies Targeting CNS Disorders Market - A Global and Regional Analysis: Focus on Drug and Region - Analysis and Forecast, 2025-2035"...

Dublin, June 23, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...